EFFECT OF A PROVIDER-FOCUSED ASTHMA CARE QUALITY IMPROVEMENT PROGRAM ON PATIENT-LEVEL ASTHMA-RELATED HEALTH CARE COSTS
Author(s)
Rojanasarot S, Carlson AM, St. Peter WL, Schommer JC
College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
OBJECTIVES Enhancing Care for Patients with Asthma (ECPA) is a real-world quality improvement program that has been executed in health centers that serve patients with asthma in Illinois, New Mexico, Texas, and Oklahoma. The ECPA focused on furnishing asthma guidelines-based processes as a structural quality improvement approach. While the ECPA has been implemented in these states since 2013, the translational and sustainable effect on reducing patient-level health care costs is unknown. The study objective was to examine the effect of this multi-state, multi-center quality improvement program on individual-level asthma-related health care costs. METHODS This study employed a pretest-posttest quasi-experimental design and utilized administrative claims data from a private insurer providing coverage to patients receiving asthma care from participating health centers. Patients were attributed to a health center if they had at least one asthma claim in a participating center during the 12-month pre-implementation and 12-month active implementation periods. Asthma-related total annual health care costs per patient were determined during pre-implementation, implementation, and post-program completion. Three-level generalized linear mixed models (GLMMs) with lognormal distribution estimated the ECPA effect on annual health care costs and accounted for correlation of repeated outcome measures of each patient and nested health centers. All costs were inflated to constant U.S. dollars. RESULTS CONCLUSIONS Asthma quality improvement efforts at the health center level are associated with sustainable reductions in asthma-related ER and total health care costs measured at the patient level.
Conference/Value in Health Info
2018-05, ISPOR 2018, Baltimore, MD, USA
Value in Health, Vol. 21, S1 (May 2018)
Code
HE1
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Respiratory-Related Disorders